These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37638968)

  • 1. Edoxaban for 12 Months Versus 3 Months in Patients With Cancer With Isolated Distal Deep Vein Thrombosis (ONCO DVT Study): An Open-Label, Multicenter, Randomized Clinical Trial.
    Yamashita Y; Morimoto T; Muraoka N; Oyakawa T; Umetsu M; Akamatsu D; Nishimoto Y; Sato Y; Takada T; Jujo K; Minami Y; Ogihara Y; Dohi K; Fujita M; Nishikawa T; Ikeda N; Hashimoto G; Otsui K; Mori K; Sueta D; Tsubata Y; Shoji M; Shikama A; Hosoi Y; Tanabe Y; Chatani R; Tsukahara K; Nakanishi N; Kim K; Ikeda S; Mo M; Yoshikawa Y; Kimura T;
    Circulation; 2023 Nov; 148(21):1665-1676. PubMed ID: 37638968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of renal function on clinical outcomes of patients with cancer-associated isolated distal deep vein thrombosis: Insights from the ONCO DVT study.
    Sueta D; Yamashita Y; Morimoto T; Muraoka N; Umetsu M; Nishimoto Y; Takada T; Ogihara Y; Nishikawa T; Ikeda N; Otsui K; Tsubata Y; Shoji M; Shikama A; Hosoi Y; Tanabe Y; Chatani R; Tsukahara K; Nakanishi N; Kim K; Ikeda S; Mo M; Kimura T; Tsujita K;
    Thromb Res; 2024 Mar; 235():107-115. PubMed ID: 38335565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial.
    Raskob GE; van Es N; Segers A; Angchaisuksiri P; Oh D; Boda Z; Lyons RM; Meijer K; Gudz I; Weitz JI; Zhang G; Lanz H; Mercuri MF; Büller HR;
    Lancet Haematol; 2016 Aug; 3(8):e379-87. PubMed ID: 27476789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
    Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
    JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study.
    Piazza G; Mani V; Goldhaber SZ; Grosso MA; Mercuri M; Lanz HJ; Schussler S; Hsu C; Chinigo A; Ritchie B; Nadar V; Cannon K; Pullman J; Concha M; Schul M; Fayad ZA;
    Vasc Med; 2016 Aug; 21(4):361-8. PubMed ID: 27165711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study.
    Brekelmans MP; Ageno W; Beenen LF; Brenner B; Buller HR; Chen CZ; Cohen AT; Grosso MA; Meyer G; Raskob G; Segers A; Vanassche T; Verhamme P; Wells PS; Zhang G; Weitz JI
    Lancet Haematol; 2016 Sep; 3(9):e437-45. PubMed ID: 27570090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.
    Raskob GE; van Es N; Verhamme P; Carrier M; Di Nisio M; Garcia D; Grosso MA; Kakkar AK; Kovacs MJ; Mercuri MF; Meyer G; Segers A; Shi M; Wang TF; Yeo E; Zhang G; Zwicker JI; Weitz JI; Büller HR;
    N Engl J Med; 2018 Feb; 378(7):615-624. PubMed ID: 29231094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of distal deep vein thrombosis.
    Kirkilesis G; Kakkos SK; Bicknell C; Salim S; Kakavia K
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD013422. PubMed ID: 32271939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study.
    Raskob G; Ageno W; Cohen AT; Brekelmans MP; Grosso MA; Segers A; Meyer G; Verhamme P; Wells PS; Lin M; Winters SM; Weitz JI; Büller HR
    Lancet Haematol; 2016 May; 3(5):e228-36. PubMed ID: 27132697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of edoxaban for treatment of venous thromboembolism: a subanalysis of East Asian patients in the Hokusai-VTE trial.
    Nakamura M; Wang YQ; Wang C; Oh D; Yin WH; Kimura T; Miyazaki K; Abe K; Mercuri M; Lee LH; Segers A; Büller H
    J Thromb Haemost; 2015 Sep; 13(9):1606-14. PubMed ID: 26179767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis.
    Wang X; Ma Y; Hui X; Li M; Li J; Tian J; Wang Q; Yan P; Li J; Xie P; Yang K; Yao L
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD010956. PubMed ID: 37058421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of Late Venous Thromboembolic Events After Acute Isolated Superficial Vein Thrombosis in Daily Practice: 12 Month Results of the INSIGHTS-SVT Study.
    Rabe E; Hoffmann U; Schimke A; Heinken A; Langer F; Noppeney T; Pittrow D; Klotsche J; Gerlach HE; Bauersachs R;
    Eur J Vasc Endovasc Surg; 2023 Nov; 66(5):697-704. PubMed ID: 37573936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical course of isolated distal deep vein thrombosis in patients with active cancer: a multicenter cohort study.
    Dentali F; Pegoraro S; Barco S; di Minno MND; Mastroiacovo D; Pomero F; Lodigiani C; Bagna F; Sartori M; Barillari G; Mumoli N; Napolitano M; Passamonti SM; Benedetti R; Ageno W; Di Nisio M
    J Thromb Haemost; 2017 Sep; 15(9):1757-1763. PubMed ID: 28639418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study.
    Di Nisio M; van Es N; Carrier M; Wang TF; Garcia D; Segers A; Weitz J; Buller H; Raskob G
    J Thromb Haemost; 2019 Nov; 17(11):1866-1874. PubMed ID: 31271705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months.
    Agnelli G; Hoffmann U; Hainaut P; Gaine S; Ay C; Coppens M; Schindewolf M; Jimenez D; Brüggenjürgen B; Levy P; Laeis P; Fronk EM; Zierhut W; Malzer T; Manu MC; Reimitz PE; Bramlage P; Cohen AT;
    Thromb Res; 2020 Dec; 196():297-304. PubMed ID: 32950897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of recurrent venous thromboembolism and bleeding complications in patients with cancer and isolated distal deep vein thrombosis.
    Brown C; Brandt W; Wang TF; Delluc A; Carrier M
    Thromb Res; 2023 Aug; 228():81-84. PubMed ID: 37301116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal duration of low molecular weight heparin for the treatment of cancer-related deep vein thrombosis: the Cancer-DACUS Study.
    Napolitano M; Saccullo G; Malato A; Sprini D; Ageno W; Imberti D; Mascheroni D; Bucherini E; Gallucci P; D'Alessio A; Prantera T; Spadaro P; Rotondo S; Di Micco P; Oriana V; Urbano O; Recchia F; Ghirarduzzi A; Lo Coco L; Mancuso S; Casuccio A; Rini GB; Siragusa S
    J Clin Oncol; 2014 Nov; 32(32):3607-12. PubMed ID: 25267738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
    ; Büller HR; Décousus H; Grosso MA; Mercuri M; Middeldorp S; Prins MH; Raskob GE; Schellong SM; Schwocho L; Segers A; Shi M; Verhamme P; Wells P
    N Engl J Med; 2013 Oct; 369(15):1406-15. PubMed ID: 23991658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis.
    Franco L; Giustozzi M; Agnelli G; Becattini C
    J Thromb Haemost; 2017 Jun; 15(6):1142-1154. PubMed ID: 28316124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study.
    Medina A; Raskob G; Ageno W; Cohen AT; Brekelmans MPA; Chen CZ; Grosso MA; Mercuri MF; Segers A; Verhamme P; Vanassche T; Wells PS; Lin M; Winters SM; Weitz JI; Büller HR
    Thromb Haemost; 2017 Dec; 117(12):2406-2414. PubMed ID: 29212128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.